Skip to content
Governance Register

Company

Adaptimmune Limited

Adaptimmune Limited is an active UK company (number 06456741), incorporated 2007, with 1 current director, Christopher James Hill. Source: Companies House, updated 4th October 2026.

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Adaptimmune Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 19

  1. William Charles Bertrand 2025-2025 Director View profile
  2. Gavin Wood 2020-2025 Director View profile
  3. Margaret Henry 2019-2025 Director View profile
  4. Adrian George Rawcliffe 2017-2025 Director View profile
  5. Dr Helen Katrina Tayton-Martin 2017-2025 Director View profile
  6. Dr C Elliott Sigal 2014-2017 Director View profile
  7. David Morrell Mott 2014-2017 Director View profile
  8. Dr Peter Armstrong Thompson 2014-2017 Director View profile
  9. Dr Ali Behbahani 2014-2017 Director View profile
  10. Helen Katrina Tayton-Martin 2011-2014 Director View profile
  11. Dr Jonathan Kenneth Charles Knowles 2011-2016 Director View profile
  12. Ian Michael Laing 2008-2016 Director View profile
  13. George Edward Silvanus Robinson 2008-2014 Director View profile
  14. James Julian Noble 2008-2019 Director View profile
  15. Nicholas John Cross 2008-2014 Director View profile
  16. Dr Bent Karsten Jakobsen 2008-2014 Director View profile
  17. Patrick Charles Morrish Baddeley 2007-2008 Director View profile
  18. Margaret Henry 2014-2025 Secretary View profile
  19. Aldwych Secretaries Limited 2007-2014 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
19/12/2007

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Adaptimmune Limited is controlled by Adaptimmune Therapeutics PLC
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by Adaptimmune Therapeutics PLC.

2 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

1 directors on the board

0.7y median 0.7y
average tenure
0.7y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

Portfolio (1)

0
also govern a charity

Left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 5

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • A single director - no second pair of eyes on any decision

Where to look Suggested search: a second director to remove single-point control.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
06456741
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data